Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	874	672	547	715	575	-
Market Cap Growth	284.06%	22.71%	-23.44%	24.40%	-	-
Enterprise Value	680	604	462	617	524	-44
PE Ratio	-	-12.26	-11.22	-13.60	-12.89	-
PS Ratio	25.81	20.91	25.96	43.19	76.57	-
PB Ratio	5.56	31.12	20.58	62.89	46.31	-
P/FCF Ratio	-17.02	-13.47	-9.96	97.58	-37.18	-
P/OCF Ratio	-17.03	-13.49	-9.99	78.78	-38.93	-
EV/Sales Ratio	20.10	18.79	21.92	37.28	69.80	-136.18
EV/EBITDA Ratio	-13.70	-10.00	-8.19	-10.20	-10.85	1.49
EV/EBIT Ratio	-13.54	-9.90	-8.11	-10.10	-10.71	1.46
EV/FCF Ratio	-13.13	-12.10	-8.41	84.22	-33.89	-19.34
Debt / Equity Ratio	0.00	0.02	0.02	0.02	0.04	0.01
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	0.00	-0.01	-0.01
Debt / FCF Ratio	-0.01	-0.01	-0.01	0.02	-0.03	0.17
Quick Ratio	11.35	3.05	3.28	4.87	2.61	3.47
Current Ratio	12.82	4.56	4.41	5.69	2.99	3.88
Asset Turnover	0.22	0.27	0.17	0.14	0.08	0.01
Interest Coverage	-12.81	-22.38	-1006.83	-880.85	-110.58	-139.31
Return on Equity (ROE)	-80.70%	-262.60%	-292.10%	-448.20%	-217.20%	-70.00%
Return on Assets (ROA)	-29.20%	-45.70%	-40.30%	-43.30%	-49.30%	-46.10%
Return on Capital (ROIC)	-33.51%	-286.36%	-215.80%	-528.85%	-381.35%	-107.26%
Earnings Yield	-5.13%	-8.15%	-8.91%	-7.35%	-7.76%	-
FCF Yield	-5.69%	-7.42%	-10.04%	1.02%	-2.69%	-
Buyback Yield / Dilution	-10.24%	-7.74%	-19.94%	-14.55%	-	-
Total Shareholder Return	-10.24%	-7.74%	-19.94%	-14.55%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).